Superna Life Sciences, Inc.
Pharma company with two products launching in 2011. Superna continues acquiring market-ready, niche cancer-care products for Canada.
A specialty pharma company focused on market-ready products for:
(1) Niche Canadian cancer markets,
(2) That are patent-protected with global branding platforms,
(3) In specialized areas with no dominant player,
(4) Which command premium prices,
(5) With a small customer base , and
(6) Where sales at 15-20 cancer centres drive business.
Superna's strives to build and sell by 2017 (goal: $20-30M+ annual sales and exit multiple of 3.5x sal